Senior Director, Biostatistics
Sionna Therapeutics Inc
·Today
- Salary
- $260k – $300k/yr
- Location
- Waltham, MA
- Seniority
- Director
- Education
- PhD
- Source
- Paylocity
Description
Description
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the CFTR protein. Sionna’s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR’s nucleotide-binding domain 1 (NBD1), which the company believes is central to potentially unlocking meaningful improvements in clinical outcomes and quality of life for people with CF. Leveraging over a decade of the co-founders’ extensive research on NBD1, the company is advancing a pipeline of novel small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in NBD1. Sionna is also developing a portfolio of complementary CFTR modulators that are designed to work synergistically with its NBD1 stabilizers to improve CFTR function.
Position Summary:
Sionna Therapeutics is seeking a Senior Director, Biostatistics to serve as Sionna’s internal biostatistics lead and expert, reporting to the Vice President of Clinical Development. This individual will be a key partner across key Sionna functions (including but not limited to Clinical Development, Clinical Operations, Data Management, Regulatory Affairs, and Sionna senior leadership) across all clinical and pre-clinical programs, including a Phase 2 clinical study planned to launch 1Q 2027, later-stage clinical study planning, and pipeline plans.
This role combines strategic leadership with hands-on statistical expertise, helping translate clinical objectives into a rigorous study design, clear analysis plans, and meaningful interpretation of results. The Senior Director will establish effective statistical and programming oversight while contributing to the broader clinical development strategy in a focused, fast-paced, collaborative biotechnology environment.
Responsibilities:
- Serve as the statistical lead for the planned Phase 2 study, partnering with Clinical Development, Data Management, Clinical Operations and other functions to ensure data integrity and timely execution of biostatistical components, leading the statistical analysis plan and downstream activities, and contributing to data reviews and ongoing study design and execution decisions.
- Oversee and grow, as appropriate, Sionna’s biostatistics function including oversight of Statistical Programming and other related outsourced functions; manage Biostatistics budget and long-range financial and workforce plans.
- Evaluate design options and statistical assumptions for ongoing and planned studies through modeling and simulation, as appropriate, to inform development decisions.
- Provide statistical input into Sionna’s broader clinical development plan, including later-stage study design, planning and decision-making, CRO and other key partner selection decisions and oversight, and input into Sionna’s pipeline and other nonclinical activities as needed.
- Seve as a key member of Sionna’s cross-functional Program Teams, clearly communicating statistical considerations, risks, tradeoffs, and recommendations to cross-functional colleagues and senior leadership.
- Support Regulatory interactions as needed, including authoring or reviewing statistical sections of regulatory documents and responses, and supporting regulatory interactions as a statistical subject matter expert. Ensure Sionna’s statistical work follows applicable regulatory guidance, industry standards, and company procedures.
Requirements
- Ph.D. in Biostatistics, Statistics, or a related quantitative discipline with 10+ years of relevant pharmaceutical or biotechnology experience; a master’s degree with substantial additional relevant experience will also be considered.
- Demonstrated experience independently leading the biostatistics function for global patient studies, including study design, statistical analysis plan, execution, and data interpretation. Experience supporting a program’s transition from Phase 2 into Phase 3 development is preferred.
- Strong knowledge of clinical trial methodology, including estimands, missing data, multiplicity, and sensitivity analyses.
- Experience using modeling and simulations to evaluate study designs and inform development decisions. Familiarity with adaptive designs, Bayesian methods, and longitudinal analyses is a plus.
- Experience overseeing CROs and external statistical programming providers, including ensuring accountability for quality, timelines, and budgets.
- Experience contributing to regulatory documents and health authority interactions.
- Proficiency in SAS and/or R, with the ability to review statistical code and independently explore data.
- Ability to translate complex statistical concepts into clear recommendations for clinical and business audiences.
- Strong judgment, attention to detail, and the ability to balance scientific rigor with practical execution.
- Comfort operating in a small biotechnology organization with evolving priorities and a high degree of individual ownership.
- Experience in respiratory disease, cystic fibrosis, or rare disease clinical development is a plus.
Salary Range: $260,000 - $300,000